SUBCUTANEOUS USTEKINUMAB PROVIDED CLINICAL AND BIOLOGICAL BENEFIT FOR 9/12 REFRACTORY PEDIATRIC CROHN'S DISEASE

Christine Martinez-Vinson  1     Jean-Pierre Hugot  1     Marc Bellaiche  1     Jérome Viala  1    
1 Hôpital Robert Debré,Gastroentérologie pédiatrique,Paris,France

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing